Predicting chronic GVHD outcomes: are we there yet?

Area of Science:

• Hematology
• Immunology
• Oncology

Background:

• Chronic graft-versus-host disease (GVHD) is a significant complication following allogeneic stem cell transplantation.
• Accurate prediction of patient outcomes is crucial for effective management of chronic GVHD.

Purpose of the Study:

• To evaluate the predictive value of clinician-assessed response, patient-reported outcomes (PROs), and 2014 National Institutes of Health (NIH) consensus criteria for chronic GVHD.
• To determine if these measures correlate with key patient survival endpoints.

Main Methods:

• Retrospective analysis of patients with chronic GVHD.
• Correlation of clinician assessments, PROs, and NIH response criteria with overall survival (OS) and failure-free survival (FFS).

Main Results:

• Clinician-assessed response demonstrated a strong correlation with OS and FFS in chronic GVHD patients.
• Patient-reported outcomes also showed significant predictive value for survival.
• The 2014 NIH response criteria effectively predicted important patient outcomes.

Conclusions:

• Clinician assessments, patient-reported outcomes, and NIH response criteria are valuable tools for predicting survival in chronic GVHD.
• These findings support the routine use of these measures in clinical practice for monitoring and managing chronic GVHD.